NCT03428126 2023-06-15Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon CancerM.D. Anderson Cancer CenterPhase 2 Completed29 enrolled 9 charts
NCT01750918 2021-10-29BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)NovartisPhase 1/2 Completed166 enrolled 46 charts